Proteoglycans and osteolysis.


Osteolysis is a complex mechanism resulting from an exacerbated activity of osteoclasts associated or not with a dysregulation of osteoblast metabolism leading to bone loss. This bone defect is not compensated by bone apposition or by apposition of bone matrix with poor mechanical quality. Osteolytic process is regulated by mechanical constraints, by polypeptides including cytokines and hormones, and by extracellular matrix components such as proteoglycans (PGs) and glycosaminoglycans (GAGs). Several studies revealed that GAGs may influence osteoclastogenesis, but data are very controversial: some studies showed a repressive effect of GAGs on osteoclastic differentiation, whereas others described a stimulatory effect. The controversy also affects osteoblasts which appear sometimes inhibited by polysaccharides and sometimes stimulated by these compounds. Furthermore, long-term treatment with heparin leads to the development of osteoporosis fueling the controversy. After a brief description of the principal osteoclastogenesis assays, the present chapter summarizes the main data published on the effect of PGs/GAGs on bone cells and their functional incidence on osteolysis.

DOI: 10.1007/978-1-61779-498-8_21

Cite this paper

@article{Baudhuin2012ProteoglycansAO, title={Proteoglycans and osteolysis.}, author={Marc Baud'huin and C{\'e}line Charrier and Gwenola Bougras and R{\'e}gis Brion and Fr{\'e}d{\'e}ric L{\'e}zot and Marc Padrines and Dominique Heymann}, journal={Methods in molecular biology}, year={2012}, volume={836}, pages={323-37} }